The molecule of wanting, not the reward itself, but the ache that reaches for it.
Overview
Dopamine is a catecholamine neurotransmitter and one of the most mythologized molecules in the brain. Popular culture calls it the "pleasure chemical," but that is mostly wrong. Dopamine is better understood as the molecule of wanting, the engine of motivation and pursuit rather than the satisfaction of arrival. It encodes reward prediction error: the gap between what you expected and what you got. It also governs voluntary movement and supports executive function, focus, planning, working memory. When you crave, scheme, or lean toward a goal, you are running on dopamine.
Chemically it sits at a crossroads. Dopamine is synthesized from the amino acid tyrosine by way of L-DOPA, and it is itself the direct precursor of Norepinephrine, the two catecholamines share the front half of a single assembly line, which is part of why arousal and motivation are so entangled. Its reward-prediction signal is precise: dopamine neurons fire above baseline when a reward is better than expected, stay flat when it merely matches expectation, and dip below baseline when it disappoints. Wanting, in other words, is the brain tracking surprise.
What It Does
The brain has several dopamine pathways. The mesolimbic pathway, running from the ventral tegmental area to the nucleus accumbens, drives motivation and salience. The mesocortical pathway feeds the Prefrontal Cortex and executive control, too little dopamine here and focus and working memory falter, which is one reason the region depends on well-tuned dopaminergic tone. The nigrostriatal pathway enables smooth movement, and its degeneration causes Parkinson's disease, treated by supplying L-DOPA to replenish what the dying neurons no longer make. A fourth, the tuberoinfundibular pathway, restrains prolactin release from the pituitary, which is why dopamine-blocking drugs can raise prolactin as a side effect. The dopamine system tells the brain what is worth attending to, which is why it sits at the center of both ambition and addiction, and why every addictive drug, however different its mechanism, ends up amplifying dopamine in the mesolimbic circuit.
Dopamine and Psychosis
The dopamine hypothesis of Psychosis proposes that excessive dopamine signaling in the mesolimbic pathway makes ordinary stimuli feel unbearably significant, a passing car, a stray word, a face on a screen. The brain assigns meaning where none exists, and that aberrant salience crystallizes into hallucinations and delusions. Too much signaling, in the wrong place, and the world starts speaking in code.
Why Antipsychotics Target It
Antipsychotics work by reducing dopamine signaling, but bluntly turning it off everywhere has a cost. Block the nigrostriatal pathway and you get Parkinsonian stiffness and tremor; block the mesocortical pathway and you get emotional flattening, the so-called zombie effect. The art is selective modulation.
The same receptor shows the tradeoff. A blunt antagonist slams the brakes on D2, fast and forceful, useful in acute crisis and heavy with side effects, because it also blocks the pathways it was not aiming at. A partial agonist binds the receptor and activates it only weakly, behaving like a stabilizer: dialing dopamine down where there is too much, propping it up where there is too little. Same target, two strategies: one a wall, the other a thermostat. Some of these drugs also reach the serotonin system, and a newer glutamate hypothesis suggests the dopamine drugs may be treating a disturbance that begins upstream.
Related
- Neurotransmitters, the chemical messengers dopamine belongs to
- Serotonin, the mood and modulation counterpart
- Norepinephrine, the catecholamine dopamine is made into
- Glutamate, the upstream system the newer model implicates
- Prefrontal Cortex, the executive region dopamine tunes
- The Brain, the organ these pathways wire through
- Psychosis, the state dopamine dysregulation can produce
- Consciousness: what salience and wanting ultimately shape